(Q39849489)

15 September 2017

Susceptibility of multiply antibiotic-resistant pneumococci to the new quinoline antibiotics, nalidixic acid, coumermycin, and novobiocin (English)

1 reference

15 September 2017

antibiotic resistance

1 reference

Gombert ME

1

1 reference

15 September 2017

Aulicino TM

series ordinal

2

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 December 1984

1 reference

Antimicrobial Agents and Chemotherapy

15 September 2017

1 reference

15 September 2017

26

1 reference

15 September 2017

6

1 reference

15 September 2017

933-934

1 reference

Susceptibility of multiply antibiotic-resistant pneumococci to the new beta-lactam drugs and rosaramicin

15 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180054

Antibiotic-resistant Streptococcus pneumoniae: clinical and epidemiologic aspects.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180054

Penicillin-binding proteins of multiply antibiotic-resistant South African strains of Streptococcus pneumoniae

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180054

In vitro activity of ciprofloxacin (Bay o 9867)

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180054

Emergence of Multiply Resistant Pneumococci

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180054

Pharmacokinetics and tissue penetration of ciprofloxacin

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180054

In vitro activity of CI-919 (AT-2266), an oral antipseudomonal compound

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180054

In vitro activity of norfloxacin, a quinolinecarboxylic acid, compared with that of beta-lactams, aminoglycosides, and trimethoprim

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180054

Norfloxacin disposition after sequentially increasing oral doses

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180054

20 August 2018

Identifiers

DOI

10.1128/AAC.26.6.933

1 reference

15 September 2017

1 reference

15 September 2017

PubMed publication ID

6570085

1 reference